Checkpoint Therapeutics, Inc.
CKPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $126,958 | $42,920 | $45,150 | $236,458 |
| - Cash | $6,604 | $4,928 | $12,068 | $54,735 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $120,354 | $37,992 | $33,082 | $181,723 |
| Revenue | $41 | $103 | $192 | $268 |
| % Growth | -60.2% | -46.4% | -28.4% | – |
| Gross Profit | $41 | -$43,463 | -$49,633 | -$48,185 |
| % Margin | 100% | -42,197.1% | -25,850.5% | -17,979.5% |
| EBITDA | -$56,174 | -$52,148 | -$53,882 | -$56,486 |
| % Margin | -137,009.8% | -50,629.1% | -28,063.5% | -21,077% |
| Net Income | -$56,240 | -$51,847 | -$62,624 | -$56,617 |
| % Margin | -137,170.7% | -50,336.9% | -32,616.7% | -21,125.7% |
| EPS Diluted | -1.42 | -2.77 | -7.09 | -7.45 |
| % Growth | 48.7% | 60.9% | 4.8% | – |
| Operating Cash Flow | -$31,101 | -$47,590 | -$57,554 | -$26,306 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$31,101 | -$47,590 | -$57,554 | -$26,306 |